Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lignans - Nutraceuticals World

What are you searching for?

Sign in
Research

Lignans

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication:

Breast health

Source:

Eur J Cancer Prev, June 2006;15(3):225-232.

Research:

In this study, researchers measured enterolactone (the bioactive lignan metabolite in humans) and genistein levels in 220 premenopausal women and 237 age-matched controls.

Results:

The median levels of plasma enterolactone in the case group were 6.3 nmol/l, compared to 9.7 nmol/l in the control group, while median genistein levels were a respective 4.5 and 3.7 nmol/l. The researchers noted a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone. There was no such significant association noted with genistein, and the study authors concluded that using biomarkers of phytoestrogen intake, we confirmed the strong inverse association between enterolactone and premenopausal breast cancer risk as found with dietary intake estimates. This result gives support to the potential role of mammalian lignans for breast cancer prevention among premenopausal women in Western populations.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics